NewAmsterdam Pharma (NAMS) Institutional Ownership $24.90 -0.07 (-0.28%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMS)CurrentInstitutional OwnershipPercentage89.89%Number ofInstitutional Buyers(last 12 months)37TotalInstitutional Inflows(last 12 months)$260.18MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$2.56M Get NAMS Insider Trade Alerts Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NAMS Institutional Buying and Selling by Quarter Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t NewAmsterdam Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC86,322$1.43M0.0%+1.6%0.096% 11/15/2024M&T Bank Corp27,328$454K0.0%+54.1%0.030% 11/15/2024Frazier Life Sciences Management L.P.12,855,194$213.40M8.6%+5.1%14.282% 11/15/2024Barclays PLC7,596$126K0.0%+1,813.4%0.008% 11/15/2024 XTX Topco Ltd11,265$187K0.0%N/A0.013% 11/15/2024 Wellington Management Group LLP92,223$1.53M0.0%+11.0%0.102% Get the Latest News and Ratings for NAMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp37,915$629K0.0%+168.7%0.042% 11/15/2024 Quarry LP6,500$108K0.0%+2,469.2%0.007% 11/15/2024 Readystate Asset Management LP121,000$2.01M0.0%N/A0.134% 11/15/2024 Parkman Healthcare Partners LLC105,334$1.75M0.2%-22.2%0.117% 11/15/2024 Janus Henderson Group PLC1,540,729$25.61M0.0%+51.1%1.712% 11/15/2024 Cinctive Capital Management LP66,571$1.11M0.1%+77.7%0.074% 11/15/2024 ArrowMark Colorado Holdings LLC354,975$5.89M0.1%+19.5%0.394% 11/14/2024 Bellevue Group AG7,700$128K0.0%N/A0.009% 11/14/2024 Walleye Capital LLC46,947$779K0.0%N/A0.052% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC239,283$3.97M0.0%+1,231.0%0.266% 11/13/2024 FMR LLC330,412$5.49M0.0%+35.6%0.367% 11/12/2024 HealthInvest Partners AB138,983$2.31M1.1%+83.4%0.154% 11/8/2024 Jennison Associates LLC1,020,278$16.94M0.0%+8.9%1.133% 11/5/2024 GSA Capital Partners LLP66,402$1.10M0.1%+79.9%0.074% 11/4/2024 Lisanti Capital Growth LLC42,165$700K0.2%N/A0.047% 11/4/2024 Wolverine Asset Management LLC4,944$82K0.0%-68.2%0.005% 11/4/2024 TimesSquare Capital Management LLC255,245$4.24M0.1%+3.7%0.284% 10/25/2024 abrdn plc129,060$2.14M0.0%+69.8%0.143% 10/23/2024 Moody Aldrich Partners LLC216,493$3.59M0.7%-1.9%0.241% 10/21/2024 Venture Visionary Partners LLC10,000$166K0.0%-9.1%0.011% 8/15/2024 Millennium Management LLC1,165,429$22.39M0.0%+23.0%1.295% 8/15/2024 Deerfield Management Company L.P. Series C869,250$16.70M0.3%+30.3%0.966% 8/15/2024Decheng Capital LLC400,000$7.68M2.4%N/A0.445% 8/15/2024 Affinity Asset Advisors LLC423,155$8.13M0.9%+47.9%0.470% 8/14/2024 Marshall Wace LLP21,831$419K0.0%-81.1%0.024% 8/13/2024 Sei Investments Co.24,561$472K0.0%+49.1%0.027% 8/2/2024 Wolverine Asset Management LLC15,524$298K0.0%+117.7%0.017% 7/31/2024 Banque Cantonale Vaudoise2,000$38K0.0%N/A0.002% 7/12/2024 Rosalind Advisors Inc.10,123$194K0.1%N/A0.011% 5/29/2024 Opaleye Management Inc.315,388$7.46M1.6%+18.8%0.351% 5/17/2024 Artal Group S.A.800,000$18.92M0.5%N/A0.896% 5/16/2024 Janus Henderson Group PLC636,231$15.02M0.0%N/A0.713% 5/15/2024 Baker BROS. Advisors LP96,827$2.29M0.0%N/A0.108% 5/15/2024 Affinity Asset Advisors LLC286,200$6.77M0.8%+129.0%0.321% There is a little known company that is changing warfare (Ad)With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t5/14/2024 StemPoint Capital LP80,334$1.90M0.5%N/A0.090% 5/7/2024 TimesSquare Capital Management LLC228,616$5.41M0.1%N/A0.256% 5/2/2024 Jennison Associates LLC930,851$22.02M0.0%N/A1.043% 4/10/2024 Yarbrough Capital LLC23,960$567K0.0%N/A0.027% 3/7/2024 Fcpm Iii Services B.V.11,831,461$132.16M39.2%N/A14.373% 2/15/2024 Opaleye Management Inc.265,388$2.96M0.8%N/A0.325% 2/15/2024 Parkman Healthcare Partners LLC300,750$3.36M0.5%+20.8%0.369% 2/1/2024 Wolverine Asset Management LLC8,694$97K0.0%+197.2%0.011% 11/15/2023 Affinity Asset Advisors LLC125,000$1.16M0.3%+25.0%0.153% 11/14/2023 Schonfeld Strategic Advisors LLC64,700$598K0.0%+12.9%0.079% 11/13/2023 Wolverine Asset Management LLC2,925$27K0.0%N/A0.004% 8/21/2023 Affinity Asset Advisors LLC100,000$1.19M0.4%N/A0.123% 8/15/2023 RA Capital Management L.P.9,000,000$107.01M2.0%+125.0%11.035% 8/15/2023 Bain Capital Life Sciences Investors LLC10,473,913$124.54M12.8%+26.2%12.842% 8/10/2023 Monashee Investment Management LLC95,000$1.13M0.3%N/A0.116% 8/4/2023 Maven Securities LTD25,000$297K0.0%N/A0.031% 7/19/2023 Medicxi Ventures Management Jersey Ltd2,869,565$34.12M9.6%+43.5%3.518% 7/14/2023 Venture Visionary Partners LLC10,000$119K0.0%N/A0.012% 5/9/2023 GMT Capital Corp1,083,800$14.37M0.6%+8.4%6.106% 5/8/2023 Wolverine Asset Management LLC4,819$64K0.0%N/A0.027% 2/14/2023 RA Capital Management L.P.4,000,000$43.60M0.9%N/A22.535% 2/3/2023Frazier Life Sciences Management L.P.9,341,551$101.82M6.3%N/A52.628% 2/3/2023 GMT Capital Corp1,000,000$10.90M0.5%N/A5.634% 1/31/2023 Medicxi Ventures Management Jersey Ltd2,000,000$21.80M9.2%N/A11.268% (Data available from 1/1/2016 forward) NAMS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAMS shares? During the previous two years, 47 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($213.40M), Fcpm Iii Services B.V. ($132.16M), Bain Capital Life Sciences Investors LLC ($124.54M), RA Capital Management L.P. ($107.01M), Medicxi Ventures Management Jersey Ltd ($34.12M), Janus Henderson Group PLC ($25.61M), and Millennium Management LLC ($22.39M).Learn more on NAMS's institutional investors. What percentage of NewAmsterdam Pharma stock is owned by institutional investors? 89.89% of NewAmsterdam Pharma stock is owned by institutional investors. Learn more on NAMS's institutional investor holdings. Which institutional investors have been buying NewAmsterdam Pharma stock? Of the 45 institutional investors that purchased NewAmsterdam Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fcpm Iii Services B.V. ($11.83M), Frazier Life Sciences Management L.P. ($9.97M), RA Capital Management L.P. ($9M), Medicxi Ventures Management Jersey Ltd ($2.87M), Bain Capital Life Sciences Investors LLC ($2.17M), Janus Henderson Group PLC ($1.16M), and GMT Capital Corp ($1.08M). How much institutional buying is happening at NewAmsterdam Pharma? Institutional investors have bought a total of 42,955,510 shares in the last 24 months. This purchase volume represents approximately $538.17M in transactions. Which NewAmsterdam Pharma major shareholders have been selling company stock? The following institutional investors have sold NewAmsterdam Pharma stock in the last 24 months: Marshall Wace LLP ($93.55K), Parkman Healthcare Partners LLC ($30.04K), Wolverine Asset Management LLC ($10.58K), Moody Aldrich Partners LLC ($4.17K), and Venture Visionary Partners LLC ($1K). How much institutional selling is happening at NewAmsterdam Pharma? Institutional investors have sold a total of 139,345 shares in the last 24 months. This volume of shares sold represents approximately $2.56M in transactions. Related Companies Roivant Sciences Major Shareholders Ascendis Pharma A/S Major Shareholders Legend Biotech Major Shareholders Elanco Animal Health Major Shareholders Viking Therapeutics Major Shareholders Cytokinetics Major Shareholders Blueprint Medicines Major Shareholders Lantheus Major Shareholders Nuvalent Major Shareholders Avidity Biosciences Major Shareholders This page (NASDAQ:NAMS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAMS Stock Alerts